About 1,899,356 results (1,787 milliseconds)

Lower LDL-Cholesterol Levels Still Best, Study Shows

http://feedproxy.google.com/~r/Theheartorg/~3/BS14gXnqtAo/828967
Jul 28, 2014 ... In these individuals, non-HDL cholesterol more accurately predicts residual risk." Going Low, Low, Low. This latest meta-analysis also showed ...

Long-Term Cholesterol Risk Points to Need for Earlier Testing

https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85MjIxMzbSAQA?oc=5
Dec 4, 2019 ... ... lowering non-HDL cholesterol or LDL cholesterol concentrations over a lifetime." In praising the research team's risk tool for calculating the ...

Novel Cholesterol Drug Disappoints: TRANSLATE-TIMI 70

https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85NzE0ODjSAQA?oc=5
Apr 3, 2022 ... "While vupanorsen significantly reduced triglycerides and non-HDL cholesterol, the reduction in non-HDL cholesterol of 22% to 27% was not to ...

Is Diet Outpacing Pills in Driving Down US Lipid Levels?

http://feedproxy.google.com/~r/Theheartorg/~3/THbMSSNTr6s/872665
Dec 2, 2016 ... "With increased interest in triglycerides for cardiovascular health, the continued drop of triglycerides ... Gene ...

Genetic Validation for New LDL Cholesterol-Lowering Target

http://feedproxy.google.com/~r/Theheartorg/~3/hM9S4gA_CfM/911156
Apr 1, 2019 ... 001). Oral bempedoic acid also significantly reduced non-HDL cholesterol, total cholesterol, apolipoprotein B, and C-reactive protein levels.

'Guarded Enthusiasm' Builds for PCSK9 Inhibitors

http://feedproxy.google.com/~r/Theheartorg/~3/46BAz_lpjJQ/845929
Jun 5, 2015 ... The drugs differ from statins—the traditional means of lowering LDL-cholesterol levels to reduce cardiovascular risk—in their mechanism and mode ...

‪Andreea Zurbau‬ - ‪Google Scholar‬

https://scholar.google.com/citations?user=nJdcYksAAAAJ&hl=en
Year · The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised ...

‪José van der Hoorn‬ - ‪Google Scholar‬

https://scholar.google.com/citations?user=6QaIx5cAAAAJ&hl=id
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic ...

US20050251869A1 - Animal model for raising HDL-cholesterol with ...

https://patents.google.com/patent/US20050251869A1/en
Inhibition of the action of CETP in humans raises the ratio of HDL to non-HDL-cholesterol. ... LDL fractions, and a decrease of TG in the VLDL and LDL fractions.

CA2740874A1 - Use of ppar.gamma.agonists to reduce small dense ...

https://www.google.com/patents/CA2740874A1
... non-HDL cholesterol level, e.g., below 130 mg/dL. [0124] In some ... A method of reducing triglycerides and LDL blood levels in a human having LDL ...

WO2014052790A1 - Methods for determining whether a patient ...

https://patents.google.com/patent/WO2014052790A1/en
The aim of therapy is to achieve cholesterol levels (total, LDL, HDL) that ... Subjects on simvastatin had significantly lower baseline total C, LDL-C, non ...

US20160299159A1 - System and Method for Estimating Low ...

https://patents.google.com/patent/US20160299159A1/en
LDL-C estimates using an approach as described by the present invention were derived as non-HDL-C minus triglycerides/adjustable factor in mg/dL, where the ...

New Guidelines Extend Statins to 13M More Americans

http://feedproxy.google.com/~r/Theheartorg/~3/nKBnoK6bUM4/822210
Mar 19, 2014 ... As reported by heartwire previously, the guidelines abandoned the LDL- and non–HDL-cholesterol targets that recommended physicians treat ...

How to interpret your lab ... - Houston Thyroid & Endocrine Specialists

https://sites.google.com/houstonendocrine.com/website/patientportal/results-interpretation
There are three major kinds of cholesterol, High Density Lipoprotein (HDL) , Low Density Lipoprotein (LDL), and Very Low Density Lipoprotein (VLDL). LDL ...

CA2946392A1 - Ldlr variants and their use in compositions for ...

https://patents.google.com/patent/CA2946392A1/en
Oct 29, 2015 ... Serum samples from animals were analyzed for total cholesterol (Tc), LDL, HDL ... decrease in baseline non-HDL cholesterol levels (Figure 8). With ...

HDL-Raising Drugs: No Value in the Statin Era?

http://feedproxy.google.com/~r/Theheartorg/~3/UDdaWtMEqDk/828779
Jul 23, 2014 ... In the era of widespread statin use, where LDL-cholesterol levels are pushed lower and lower, investigators say that the clinical trials ...

US10912751B2 - Fixed dose combinations and formulations ...

https://patents.google.com/patent/US10912751B2/en
The primary objective was to assess the LDL-C—lowering effect of ETC-1002 ... Cholesterol, and Non-HDL-C More than EZE Alone. ETC-1002 alone or with EZE ...

WO2008086019A1 - Device and method for measuring ldl ...

https://patents.google.com/patent/WO2008086019A1/en
In particular, if the proportion of serum cholesterol associated with LDL is high and/or the proportion associate with HDL is low, the risk of coronary disease ...

ORION-1: Novel PCSK9 Inhibitor Provides Durable LDL-C Reduction

http://feedproxy.google.com/~r/Theheartorg/~3/ScI5VnRofnM/872310
Nov 23, 2016 ... With respect to LDL-C reduction, the single dose reduced LDL-C by ... Non-HDL-C, mean, % (SD), 0 (20), -30 (13), -37 (18), -40 (19), -42 (15).